This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Danatlas Pharmaceuticals Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Zhangqi Yu in Pharmaceutical Chemistry
Introduction: Zhangqi Yu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tricyclic heterocyclic derivatives. His research focuses on the development of new therapeutic agents that can potentially improve health outcomes.
Latest Patents: Zhangqi Yu holds a patent for "Tricyclic heterocyclic derivatives, compositions and uses thereof." This patent relates to tricyclic heterocyclic derivatives as shown in Formula (I). It encompasses pharmaceutical compositions that include these derivatives, a process for their preparation, and their application as therapeutic agents. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights: Zhangqi Yu is associated with Danatlas Pharmaceuticals Co., Ltd., where he applies his expertise in drug development. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry. His contributions have the potential to lead to new treatments that can benefit patients worldwide.
Collaborations: Zhangqi Yu collaborates with talented colleagues, including Wenlai Zhou and Jincong Zhuo. These partnerships enhance the research and development efforts at Danatlas Pharmaceuticals, fostering an environment of innovation and creativity.
Conclusion: Zhangqi Yu's work in pharmaceutical chemistry exemplifies the impact of innovation on healthcare. His patent on tricyclic heterocyclic derivatives highlights his dedication to developing new therapeutic agents. Through his career and collaborations, he continues to contribute to advancements in medicine.